Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update noting completion of ASC47 evaluation in healthy and obese subjects to assess safety, tolerability, pharmacokinetics and pharmacod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ASC47

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: Chronic Weight Management | Phase 1 | Status: COMPLETED